Literature DB >> 6102753

Antigenic variation in clones of animal-infective Trypanosoma brucei derived and maintained in vitro.

J J Doyle, H Hirumi, K Hirumi, E N Lupton, G A Cross.   

Abstract

Eighteen clones of variable antigen type 052 of Trypanosoma brucei stock S.427 were derived and maintained as animal-infective bloodstream forms in vitro for up to 60 days of cultivation. The antigenic composition of such clones was monitored weekly by immunofluorescent analysis of viable trypanosomes, using antisera raised to isolated variant-specific surface glycoproteins of both 052 and variable antigen type (221) which consistently appeared in the first relapse population of type 052 in vitro. The appearance of new variants was detected in 9 of the 18 clones 18--46 days following initiation of the clone and variable antigen type 221 was found in all 9 clones. On one or more occasions in 8 of such clones, viable trypanosomes were found which did not react with either antiserum but were mouse-infective on the 4 occasions tested and probably represent other variable antigen types. The process of antigen variation in vitro appears to resemble the process in vivo except that new variant types are detected earlier in vivo. This possibly results from different growth rates of the trypanosomes in vivo and in vitro, together with the fact that elimination of the initial variant population by the host's immune response facilitates the detection of newly arising variable antigen types in vivo.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6102753     DOI: 10.1017/s0031182000000810

Source DB:  PubMed          Journal:  Parasitology        ISSN: 0031-1820            Impact factor:   3.234


  27 in total

1.  High-efficiency clonal growth of bloodstream- and insect-form Trypanosoma brucei on agarose plates.

Authors:  V B Carruthers; G A Cross
Journal:  Proc Natl Acad Sci U S A       Date:  1992-09-15       Impact factor: 11.205

2.  Isolation of two Giardia lamblia (WB strain) clones with distinct surface protein and antigenic profiles and differing infectivity and virulence.

Authors:  I A Udezulu; G S Visvesvara; D M Moss; G J Leitch
Journal:  Infect Immun       Date:  1992-06       Impact factor: 3.441

3.  Consequences of telomere shortening at an active VSG expression site in telomerase-deficient Trypanosoma brucei.

Authors:  Oliver Dreesen; George A M Cross
Journal:  Eukaryot Cell       Date:  2006-10-27

4.  Parasite-intrinsic factors can explain ordered progression of trypanosome antigenic variation.

Authors:  Katrina A Lythgoe; Liam J Morrison; Andrew F Read; J David Barry
Journal:  Proc Natl Acad Sci U S A       Date:  2007-04-26       Impact factor: 11.205

5.  CRE recombinase-based positive-negative selection systems for genetic manipulation in Trypanosoma brucei.

Authors:  Michael D Scahill; Irena Pastar; George A M Cross
Journal:  Mol Biochem Parasitol       Date:  2007-10-06       Impact factor: 1.759

Review 6.  Molecular biology of trypanosome antigenic variation.

Authors:  J E Donelson; A C Rice-Ficht
Journal:  Microbiol Rev       Date:  1985-06

7.  Antigenic variation in clones of Trypanosoma brucei grown in immune-deficient mice.

Authors:  P J Myler; A L Allen; N Agabian; K Stuart
Journal:  Infect Immun       Date:  1985-03       Impact factor: 3.441

8.  Structure and expression of two temperature-specific surface proteins in the ciliated protozoan Tetrahymena thermophila.

Authors:  G A Bannon; R Perkins-Dameron; A Allen-Nash
Journal:  Mol Cell Biol       Date:  1986-09       Impact factor: 4.272

9.  An adenosine-to-inosine tRNA-editing enzyme that can perform C-to-U deamination of DNA.

Authors:  Mary Anne T Rubio; Irena Pastar; Kirk W Gaston; Frank L Ragone; Christian J Janzen; George A M Cross; F Nina Papavasiliou; Juan D Alfonzo
Journal:  Proc Natl Acad Sci U S A       Date:  2007-05-01       Impact factor: 11.205

10.  Telomere length in Trypanosoma brucei.

Authors:  Oliver Dreesen; George A M Cross
Journal:  Exp Parasitol       Date:  2007-08-29       Impact factor: 2.011

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.